|
C2ORF49 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.102610E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.254140E-02 |
| Normal-vs-Stage2 |
1.956040E-01 |
| Normal-vs-Stage3 |
7.521800E-01 |
| Normal-vs-Stage4 |
6.701000E-01 |
| Stage1-vs-Stage2 |
6.178600E-01 |
| Stage1-vs-Stage3 |
6.541800E-03 |
| Stage1-vs-Stage4 |
1.120180E-01 |
| Stage2-vs-Stage3 |
1.368430E-01 |
| Stage2-vs-Stage4 |
4.331600E-01 |
| Stage3-vs-Stage4 |
4.883600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.638300E-02 |
| Normal-vs-AfricanAmerican |
5.147800E-01 |
| Normal-vs-Asian |
2.618300E-02 |
| Caucasian-vs-AfricanAmerican |
5.048500E-02 |
| Caucasian-vs-Asian |
2.320400E-01 |
| AfricanAmerican-vs-Asian |
8.093800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.126790E-01 |
| Normal-vs-Female |
2.147200E-01 |
| Male-vs-Female |
7.974800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.832200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.867600E-02 |
| Normal-vs-Age(61-80Yrs) |
2.191000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.948800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.023400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.822200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.761400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.066600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.226770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.372600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.063600E-02 |
| Normal-vs-Grade 2 |
7.422200E-03 |
| Normal-vs-Grade 3 |
8.105400E-01 |
| Normal-vs-Grade 4 |
9.260200E-01 |
| Grade 1-vs-Grade 2 |
4.116600E-01 |
| Grade 1-vs-Grade 3 |
6.294300E-02 |
| Grade 1-vs-Grade 4 |
9.473800E-02 |
| Grade 2-vs-Grade 3 |
5.381400E-03 |
| Grade 2-vs-Grade 4 |
2.710100E-02 |
| Grade 3-vs-Grade 4 |
7.664000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.43899999999853E-05 |
| Normal-vs-ccB subtype |
5.893400E-01 |
| ccA subtype-vs-ccB subtype |
1.07009999972263E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.894420E-01 |
| Normal-vs-N1 |
7.132400E-01 |
| N0-vs-N1 |
3.983400E-01 |
|
|
